FDA Drug Recalls

Recalls / Class II

Class IID-787-2013

Product

Trimix, compounded by Olympia Pharmacy, Orlando, FL

Affected lot / code info
B5015 Exp 8/15/13, C50001 Exp 8/28/13, B5011 Exp 8/1/13, C42215 Exp 6/22/13, A5028 Exp 6/2/13, B5011 Exp 6/1/13, B5020 Exp 6/1/13, B50112 Exp 8/11/13, C4186 Exp 6/18/13, C4158 Exp 6/15/13, C4149 Exp 6/14/13, C4111 Exp 6/11/13, B4124 Exp 8/12/13, B4154 Exp 8/15/13, B4198 Exp 8/19/13, B4226 Exp 8/22/13, B4268 Exp 8/22/13, C40522 Exp 9/5/13, C4118 Exp 9/1/13, C4711 Exp 9/7/13, C41121 Exp 9/11/13, C4126 Exp 9/12/13 and B42715 Exp 8/27/13.

Why it was recalled

Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes

Recalling firm

Firm
Lowlite Investments, Inc. D/B/A Olympia Pharmacy
Notification channel
Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit
Type
Voluntary: Firm initiated
Address
6700 Conroy Windermere Rd, Suite 140, Orlando, Florida 32835-3500

Distribution

Quantity
24
Distribution pattern
Nationwide and PR

Timeline

Recall initiated
2013-05-29
FDA classified
2013-07-11
Posted by FDA
2013-07-17
Status
Ongoing

Source: openFDA Drug Enforcement endpoint. Recall record D-787-2013. The FDA issues recall classifications as health-hazard assessments, not legal findings; for legal claims consult a licensed attorney.